Is a complete BCBA/AZN research report available?

No complete published report is available for bcba/AZN (BCBA/AZN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bcba/AZN stock profile: metrics, valuation and analysis

Market cap	379.5T
Revenue (ttm)	90.9T
Net income (ttm)	15.5T
EPS (ttm)	ARS 9,896
P/E (trailing)	24.5x
P/E (forward)	15.0x
Dividend	ARS 1,079 (1.67%)
Volume	335

All BCBA/AZN indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	AR
Employees	96,100
Employees Change	1,800%
Employees Change Percent	1.91
Enterprise value	ARS 421.6T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-09-08
Market cap	ARS 379.5T
Price	ARS 64,925
Price currency	ARS
Rev Per Employee	946,032,559.83x
Sic	2834
Symbol	bcba/AZN
Website	https://www.astrazeneca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.08%
EV Earnings	27.25x
EV/EBIT	18.77x
EV/EBITDA	13.53x
EV/FCF	26.68x
EV/Sales	4.47x
FCF yield	4.16%
Forward P/E	15x
P/B ratio	5.09x
P/E ratio	24.52x
P/S ratio	4.17x
PE Ratio10 Y	84.65x
PE Ratio3 Y	30.99x
PE Ratio5 Y	130.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.86%
EBITDA Margin	32.43%
FCF margin	17.08%
Gross margin	81.69%
Gross Profit	ARS 74.3T
Gross Profit Growth	7.69%
Gross Profit Growth Q	7.25%
Gross Profit Growth3 Y	9.19%
Gross Profit Growth5 Y	17.24%
Net Income	ARS 15.5T
Net Income Growth	25.93%
Net Income Growth Q	2.33%
Net Income Growth Qo Q	-18.6%
Net Income Growth3 Y	19.23%
Net Income Growth5 Y	22.6%
Pretax Margin	20.51%
Profit Margin	17.02%
Profit Per Employee	ARS 161M
ROA	8.02
Roa5y	5.95
ROCE	17.37
ROE	21.96
Roe5y	13.03
ROIC	16.05
Roic5y	13.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	14.62%
Cagr3y	38.07%
Cagr5y	66.41%
Div CAGR10	44.69%
Div CAGR3	95.89%
Div CAGR5	109.35%
EPS Growth	25.84
EPS Growth Q	2.55
EPS Growth Qo Q	-18.27
EPS Growth3 Y	19.13
EPS Growth5 Y	18.4
FCF Growth	-4.55%
FCF Growth Q	-22.92%
FCF Growth Qo Q	-25.25%
FCF Growth3 Y	5.66%
FCF Growth5 Y	14.81%
OCF Growth	2.32%
OCF Growth Q	-15.39%
OCF Growth Qo Q	-14.71%
OCF Growth10 Y	14.02%
OCF Growth3 Y	10.41%
OCF Growth5 Y	16.27%
Revenue Growth	8.61x
Revenue Growth Q	6.41x
Revenue Growth Qo Q	0.63x
Revenue Growth3 Y	11.32x
Revenue Growth5 Y	15.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.54
Assets	ARS 171.6T
Cash	ARS 7.4T
Current Assets	ARS 42.2T
Current Liabilities	ARS 47.6T
Debt	ARS 47.9T
Debt EBITDA	ARS 1.59
Debt Equity	ARS 0.64
Debt FCF	ARS 3.03
Equity	ARS 74.6T
Interest Coverage	10.4
Liabilities	ARS 97T
Long Term Assets	ARS 129.4T
Long Term Liabilities	ARS 49.4T
Net Cash	ARS -40.6T
Net Cash By Market Cap	ARS -10.69
Net Debt EBITDA	ARS 1.38
Net Debt Equity	ARS 0.54
Net Debt FCF	ARS 2.57
Tangible Book Value	ARS -12.8T
Tangible Book Value Per Share	ARS -8,223

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.89
Inventory Turnover	1.68
Net Working Capital	ARS -3.3T
Quick ratio	0.66
Working Capital	ARS -5.3T
Working Capital Turnover	ARS -22,215

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.03%
Dividend Growth	35.63%
Dividend Growth Years	4%
Dividend per share	ARS 1,079
Dividend Years	5
Dividend Yield	1.67%
Ex Div Date	2026-08-07
Last Dividend	ARS 396
Payout Frequency	Semi-Annual
Payout Ratio	45.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	14.61%
200-day SMA	69,380.9
3Y total return	163.25%
50-day SMA	67,040
50-day SMA vs 200-day SMA	50under200
5Y total return	1,175.55%
All Time High	80,275
All Time High Change	-20.15%
All Time High Date	2026-07-03
All Time Low	3,038
All Time Low Change	2,009.94%
All Time Low Date	2020-09-04
ATR	1,826
Ch YTD	-9.14
High	68,000
High52	80,275
High52 Date	2026-07-03
High52ch	-19.12%
Low	61,000
Low52	50,650
Low52 Date	2025-09-25
Low52ch	28.18%
Ma50ch	-4.39%
Price vs 200-day SMA	-7.61%
RSI	47.82
RSI Monthly	58.45
RSI Weekly	46.64
Sharpe ratio	0.66x
Sharpe Ratio3y	1.15x
Sharpe Ratio5y	1.42x
Sortino ratio	1.12
Sortino Ratio3y	1.94
Sortino Ratio5y	2.37
Total Return	1.7%
Tr YTD	-7.73
Tr1m	1.7%
Tr1w	-1.35%
Tr3m	-8.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,542,971,203%
Net Borrowing	-2,846,928,416,000
Shares Insiders	0.04%
Shares Institutions	74.06%
Shares Qo Q	-0.06%
Shares Yo Y	-0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 15.3T
Adjusted OCF	19,754,321,000,000
Average Volume	1,696.85x
Bv Per Share	48,041.3
CAPEX	ARS -4.5T
Ch1m	1.06
Ch1w	-1.35
Ch1y	12.85
Ch3m	-8.59
Ch3y	151.3
Ch5y	1,102.6
Ch6m	-11.1
Change	0.58%
Change From Open	0.58
Close	64,550
Days Gap	0
Depreciation Amortization	7,939,130,355,000
Dollar Volume	21,749,875
Earnings Date	2026-10-30
EBIT	ARS 21.7T
EBITDA	ARS 29.5T
EPS	ARS 9,896
F Score	7
FCF	ARS 15.8T
FCF EV Yield	3.75x
Financing CF	-11,377,920,000,000
Fiscal Year End	December
Founded	1,992
Goodwill	31,938,978,167,000
Graham Number	27420.55622
Graham Upside	-57.52
Income Tax	ARS 3.2T
Investing CF	-12,075,706,500,000
Is Primary Listing	0
Last Earnings Date	2026-07-27
Last Report Date	2026-06-30
Lynch Fair Value	ARS 59,501
Lynch Upside	-7.82
Ma150	69,507.7
Ma150ch	-7.78%
Ma20	64,761.3
Ma20ch	-1.02%
Net CF	-3,182,262,000,000
Next Earnings Date	2026-10-30
Open	64,550
P FCF Ratio	24.01
P FCF Ratio SBC	24.86
P OCF Ratio	18.7
P OCF Ratio SBC	19.21
Payment Date	2026-09-08
Position In Range	56.07
Ppne	24,578,884,100,000
Price Date	2026-09-07
Price EBITDA	ARS 12.87
Relative Volume	0.2x
Revenue	90,913,729,000,000x
SBC By Revenue	0.6x
Share Based Comp	542,229,000,000
Tax By Revenue	3.48x
Tax Rate	16.95%
Tr6m	-10.54%
Volume	335
Z Score	3.57

BCBA/AZN (BCBA/AZN)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/AZN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/AZN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BCBA/AZN

Frequently asked questions